SCHEMBL30125994

SCHEMBL30125994

CC(C)(C)OC(=O)N1CCCC(c2ccc3ncnc(Cl)c3c2)C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 1/20 0.47
▸ PIK3CD O00329 4/20 0.47
▸ PIK3CA P42336 3/20 0.47
▸ PIK3CB P42338 2/20 0.47
▸ PIK3CG P48736 2/20 0.47
▸ HPGDS O60760 2/20 0.45
▸ JAK2 O60674 1/20 0.44
▸ JAK1 P23458 1/20 0.44
▸ IRAK4 Q9NWZ3 1/20 0.42
▸ PRMT5 O14744 1/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ PROKR1 Q8TCW9 3/20 0.40
▸ TP53 P04637 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30127280 0.95 PDE4B (0.52) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30126593 0.91 PIK3CD (0.44) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30127359 0.89 PDE4B (0.48) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30127386 0.84 HPGDS (0.45) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30126000 0.84 PDE4B (0.53) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30125786 0.82 PIK3CD (0.48) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30125952 0.82 PIK3CD (0.48) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30127558 0.82 PIK3CD (0.48) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30126934 0.82 PIK3CD (0.48) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL30126933 0.79 PIK3CD (0.44) PDE4BPIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266458-A1 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 — — WO disclosed
Send feedback